COVID-19 World Rare Disease Drug Market Research Report (by Product Type, End-User/Application and Regions/Countries)

September 2020 | 135 pages | ID: CBE366F057C1EN
HeyReport

Abstracts

SUMMARY


This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Rare Disease Drug , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Rare Disease Drug market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• Asia-Pacific (China, India, Japan, Southeast Asia etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

• >1
• 0.65 1
• <0.1

By End-User / Application

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

By Company

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.
• Deciphera
• Atara Biotherapeutics
• ProQR

Contents

PART 1 MARKET DEFINITION

1.1 Market Segment Overview
Figure Global Rare Disease Drug Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Rare Disease Drug Market and Growth by Type
1.3 by End-Use / Application
Table Global Rare Disease Drug Market and Growth by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
Table Global Rare Disease Drug Revenue (Million USD) by Vendors (2017-2019)
Table Global Rare Disease Drug Revenue Share by Vendors (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by Vendors (2017-2019)
Table Global Rare Disease Drug Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
Table Global Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Global Rare Disease Drug Market Share by Type (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by Type (2017-2019)
Table Global Rare Disease Drug Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
Table Global Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Global Rare Disease Drug Market Share by End-Use / Application (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Rare Disease Drug Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
Table Global Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Global Rare Disease Drug Market Share by Regions (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by Regions (2017-2019)
Table Global Rare Disease Drug Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
  5.2.1 North America
Figure North America Market Growth 2015-2018
  5.2.2 Europe
Figure Europe Market Growth 2017-2019
  5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
  5.2.4 South America
Figure South America Market Growth 2017-2019
  5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019

6 NORTH AMERICA MARKET

6.1 by Type
Table North America Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table North America Rare Disease Drug Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table North America Rare Disease Drug Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table North America Rare Disease Drug Market Share by Regions (2017-2019)

7 EUROPE MARKET

7.1 by Type
Table Europe Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Europe Rare Disease Drug Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Rare Disease Drug Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Europe Rare Disease Drug Market Share by Regions (2017-2019)

8 ASIA-PACIFIC MARKET

8.1 by Type
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Rare Disease Drug Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Rare Disease Drug Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Rare Disease Drug Market Share by Regions (2017-2019)

9 SOUTH AMERICA MARKET

9.1 by Type
Table South America Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table South America Rare Disease Drug Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table South America Rare Disease Drug Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2017-2019)

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2017-2019)

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
Figure Global Rare Disease Drug Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Rare Disease Drug Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market (Million USD) Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market Share Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Rare Disease Drug Market (Million USD) Forecast by Type (2020-2025)
Table Global Rare Disease DrugMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Rare Disease Drug Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Rare Disease Drug Market Share Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS


12.CHINA MINMETALS CORPORATION NOVARTIS AG

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
12.2 Bristol-Myers Squibb Company
12.3 Celgene Corporation
12.4 F. Hoffmann-La Roche Ltd.
12.5 Pfizer, Inc.
12.6 Sanofi S.A.
12.7 Alexion Pharmaceuticals, Inc.
12.8 Eli Lilly and Company
12.9 Novo Nordisk A/S
12.10 AstraZeneca
12.11 Eisai Co., Ltd.
12.12 Daiichi Sankyo Company Limited
12.13 Bayer AG
12.14 GlaxoSmithKline
12.15 Merck & Co., Inc.
12.16 Johnson & Johnson
12.17 Biogen, Inc.
12.18 Shire
12.19 Amgen, Inc.
12.20 Deciphera
12.21 Atara Biotherapeutics
12.22 ProQR

13 OVERVIEW OF INDUSTRY DEVELOPMENT (COVID-19)

13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)

14 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Rare Disease Drug Market and Growth by Type
Table Global Rare Disease Drug Market and Growth by End-Use / Application
Table Global Rare Disease Drug Revenue (Million USD) by Vendors (2017-2019)
Table Global Rare Disease Drug Revenue Share by Vendors (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by Vendors (2017-2019)
Table Global Rare Disease Drug Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Global Rare Disease Drug Market Share by Type (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by Type (2017-2019)
Table Global Rare Disease Drug Market Volume Share by Type (2017-2019)
Table Global Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Global Rare Disease Drug Market Share by End-Use / Application (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Rare Disease Drug Market Volume Share by End-Use / Application (2017-2019)
Table Global Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Global Rare Disease Drug Market Share by Regions (2017-2019)
Table Global Rare Disease Drug Market Volume (Volume) by Regions (2017-2019)
Table Global Rare Disease Drug Market Volume Share by Regions (2017-2019)
Table North America Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table North America Rare Disease Drug Market Share by Type (2017-2019)
Table North America Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table North America Rare Disease Drug Market Share by End-Use / Application (2017-2019)
Table North America Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table North America Rare Disease Drug Market Share by Regions (2017-2019)
Table Europe Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Europe Rare Disease Drug Market Share by Type (2017-2019)
Table Europe Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Rare Disease Drug Market Share by End-Use / Application (2017-2019)
Table Europe Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Europe Rare Disease Drug Market Share by Regions (2017-2019)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Rare Disease Drug Market Share by Type (2017-2019)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Rare Disease Drug Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Rare Disease Drug Market Share by Regions (2017-2019)
Table South America Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table South America Rare Disease Drug Market Share by Type (2017-2019)
Table South America Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table South America Rare Disease Drug Market Share by End-Use / Application (2017-2019)
Table South America Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2017-2019)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by Type (2017-2019)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Rare Disease Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Rare Disease Drug Market Share by Regions (2017-2019)
Table Global Rare Disease Drug Market (Million USD) Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market Share Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market Volume Share Forecast by Regions (2020-2025)
Table Global Rare Disease Drug Market (Million USD) Forecast by Type (2020-2025)
Table Global Rare Disease DrugMarket Share by Forecast Type (2020-2025)
Table Global Rare Disease Drug Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Rare Disease Drug Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Company
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi S.A.
Table Sales Revenue, Volume, Price, Cost and Margin of Alexion Pharmaceuticals, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk A/S
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai Co., Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo Company Limited
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer AG
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Merck & Co., Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Biogen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Shire
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Deciphera
Table Sales Revenue, Volume, Price, Cost and Margin of Atara Biotherapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of ProQR

List Of Figures

LIST OF FIGURES

Figure Global Rare Disease Drug Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Rare Disease Drug Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Rare Disease Drug Market Volume (Volume) and Growth Forecast (2020-2025)